C7ORF44 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.24490023529256E-10 |
Normal-vs-Stage2 |
3.198700E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
6.012900E-04 |
Stage1-vs-Stage2 |
3.966600E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
6.191400E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
7.933400E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.63080660087189E-12 |
Normal-vs-AfricanAmerican |
6.568400E-02 |
Normal-vs-Asian |
5.597800E-02 |
Caucasian-vs-AfricanAmerican |
7.795600E-02 |
Caucasian-vs-Asian |
5.295400E-01 |
AfricanAmerican-vs-Asian |
1.017840E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.89069999989577E-07 |
Normal-vs-Female |
3.76769726528892E-11 |
Male-vs-Female |
9.022500E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
4.155100E-04 |
Normal-vs-Extreme_Weight |
9.15950004731769E-09 |
Normal-vs-Obese |
2.807600E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
4.983400E-01 |
Normal_Weight-vs-Obese |
7.351400E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
7.982800E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.059600E-02 |
Normal-vs-Age(41-60Yrs) |
2.74340000050444E-07 |
Normal-vs-Age(61-80Yrs) |
3.19389958924887E-10 |
Normal-vs-Age(81-100Yrs) |
3.610600E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.772600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.902800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.144600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.256070E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.584000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.579400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
3.720400E-01 |
Normal-vs-Grade 3 |
9.448500E-02 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
1.340380E-01 |
Grade 2-vs-Grade 4 |
3.720400E-01 |
Grade 3-vs-Grade 4 |
9.448500E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.42144107384956E-12 |
Normal-vs-N1 |
1.184890E-03 |
N0-vs-N1 |
6.475800E-01 |
|
|